Cycle Checkpoint Abnormalities during Dementia: A Plausible Association with the Loss of Protection against Oxidative Stress in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
BACKGROUND: Increasing evidence suggests an association between neuronal cell cycle (CCL) events and the processes that underlie neurodegeneration in Alzheimer's disease (AD). Elevated levels of oxidative stress markers and mitochondrial dysfunction are also among early events in AD. Recent studies have reported the role of CCL checkpoint proteins and tumor suppressors, such as ATM and p53 in the control of glycolysis and oxidative metabolism in cancer, but their involvement in AD remains uncertain. METHODS AND FINDINGS: In this postmortem study, we measured gene expression levels of eight CCL checkpoint proteins in the superior temporal cortex (STC) of persons with varying severities of AD dementia and compare them to those of cognitively normal controls. To assess whether the CCL changes associated with cognitive impairment in AD are specific to dementia, gene expression of the same proteins was also measured in STC of persons with schizophrenia (SZ), which is also characterized by mitochondrial dysfunction. The expression of CCL-checkpoint and DNA damage response genes: MDM4, ATM and ATR was strongly upregulated and associated with progression of dementia (cognitive dementia rating, CDR), appearing as early as questionable or mild dementia (CDRs 0.5-1). In addition to gene expression changes, the downstream target of ATM-p53 signaling - TIGAR, a p53-inducible protein, the activation of which can regulate energy metabolism and protect against oxidative stress was progressively decreased as severity of dementia evolved, but it was unaffected in subjects with SZ. In contrast to AD, different CCL checkpoint proteins, which include p53, CHEK1 and BRCA1 were significantly downregulated in SZ. CONCLUSIONS: These results support the activation of an ATM signaling and DNA damage response network during the progression of AD dementia, while the progressive decrease in the levels of TIGAR suggests loss of protection initiated by ATM-p53 signaling against intensifying oxidative stress in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies have reported alterations in DNA repair proteins (cell-cycle checkpoint proteins and tumor suppressors) of pathways involved in the repair of oxidative stress-induced lesions in patients with AD [28], [79].”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 2×
“Filtering conditions were a combination of confidence (p#0.05) and fold change ($1.4) with Benjamini and Hochberg [81] multiple testing corrections.”
MethodInfluentialNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 13×
“These findings suggest strong downregulation of TIGAR expression associated with measures of dementia severity but not conventional measures of AD neuropathology (NP density and Braak scores).”
MethodInfluentialThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
(2016) · Repository@Hull (Worktribe) (University of Hull) · doi:10.1111/j.1365 · Cited by 5,304
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 5×
“Demographics and CERAD Classification of the Dementia Cohort The demographic characteristics of the study cohorts are shown in Tables S1 and S2.”
MethodInfluentialA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 2×
“Ataxia telangiectasia (A-T) is a human disease caused by ATM deficiency and characterized by the failure of CCL checkpoints, predisposition to cancer, immunodeficiency and by neurologic abnormalities caused by significant loss of neurons [34].”
BackgroundConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Self-citationTIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 4×
“the loss of protection by the TP53-inducible survival signals [38].”
BackgroundInfluentialGene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874 · cited 3×
“It is generally accepted, that accumulation of DNA damage and its impaired repair mechanism is a prominent feature of aging in the CNS [46], and the impairment of this process is believed to be exacerbated in dementia and AD [47–49].”
BackgroundInfluential
Cited by
Myelination, oligodendrocytes, and serious mental illness
Haroutunian, V., Katsel, P., Roussos, P., Davis, K. L., Altshuler, L. L., & Bartzokis, G. (2014) · Glia · doi:10.1002/glia.22716 · Cited by 248
“That the cell-cycle program is affected in SZ has been demonstrated in several studies (Benes et al., 2009; Katsel et al., 2013; Kerns et al., 2010; McCurdy et al., 2006) and its association with OMR deficits has been suggested (Katsel et al., 2013).”
BackgroundSelf-citationp53 and mitochondrial function in neurons
Wang, D. B., Kinoshita, C., Kinoshita, Y., & Morrison, R. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.015 · Cited by 167
Tewari, D., Stankiewicz, A. M., Mocan, A., Sah, A. N., Tzvetkov, N. T., Huminiecki, Ł., Horbańczuk, J. O., & Atanasov, A. G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00003 · Cited by 151
“…Favaloro et al., 2012); (11) Impaired calcium signaling (Berridge, 2011; Nimmrich and Eckert, 2013); (12) Changes in cell cycle (Raina et al., 2000; Katsel et al., 2013); (13) Presence of neuroinflammation (Pasqualetti et al., 2015); (14) Increased oxidative stress (Bennett et al., 2009; Kumar and…”
BackgroundX chromosome aneuploidy in the Alzheimer’s disease brain
Yurov, Y. B., Vorsanova, S. G., Liehr, T., Kolotii, A. D., & Iourov, I. Y. (2014) · Molecular Cytogenetics · doi:10.1186/1755-8166-7-20 · Cited by 140
“abortive cell cycle due to reentering of quiescent neurons into the cell cycle and replication stress) [43] that leads to genome/chromosome instability similar to cancer manifesting as aneuploidy or chromosomal double-strand breaks, resulting, however, in neurodegeneration [44]; the idea is also supported by observati…”
BackgroundConnecting the dots between tau dysfunction and neurodegeneration
Frost, B., Götz, J., & Feany, M. B. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.005 · Cited by 124
“Mechanism Potential Targets Drug Effort Tau Hyperphosphorylation/Misfolding PAR-1* GSK-3β* HSPs* Lithium Methylene Blue Tideglusib** Nicotinomide** Valproic Acid** LMT-X** Sodium Selenate** Compound A* Thiamet-G* SNR-003-556* Tau Spread HSPGs MC1 Antibody * PHF1 Antibody* Synapse Loss STEP NMDAR Fyn MEM 1003 Neramexan…”
BackgroundInfluentialTse, K., & Herrup, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14079 · Cited by 105
“Despite these regional differences in ATM activity and expression, the abnormal re-expression of cell cycle elements is a common finding in the AD brain and its severity is linked with cognitive impairments (Chen et al. 2010; Katsel et al. 2013; Shen et al. 2016).”
BackgroundThe interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease
Jazvinšćak Jembrek, M., Slade, N., Hof, P. R., & Šimić, G. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.05.001 · Cited by 100
“mentia increases, suggesting that optimal TIGAR levels offers protection against oxidative damage (Katsel et al., 2013).”
Silva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099897 · Cited by 99
“Recent studies have reported alterations in DNA repair proteins (cell-cycle checkpoint proteins and tumor suppressors) of pathways involved in the repair of oxidative stress-induced lesions in patients with AD [28,79].”
BackgroundStructure, regulation, and biological functions of TIGAR and its role in diseases
Tang, J., Chen, L., Qin, Z., & Sheng, R. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00588-y · Cited by 94
Molecular signature of extracellular matrix pathology in schizophrenia
Pantazopoulos, H., Katsel, P., Haroutunian, V. H., Chelini, G., Klengel, T., & Berretta, S. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15009 · Cited by 84
Self-citationLoss of TOP3B leads to increased R-loop formation and genome instability
Zhang, T., Wallis, M., Petrovic, V., Challis, J., Kalitsis, P., & Hudson, D. F. (2019) · Open Biology · doi:10.1098/rsob.190222 · Cited by 78
Lei, B., Liu, J., Yao, Z., Xiao, Y., Zhang, X., Zhang, Y., & Xu, J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.653881 · Cited by 69
Hassan, M., Raza, H., Abbasi, M. A., Moustafa, A. A., & Seo, S.-Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.115 · Cited by 61
Katsel, P., Roussos, P., Fam, P. S., Khan, S., Tan, W., Hirose, T., Nakagawa, S., Pletnikov, M. V., & Haroutunian, V. H. (2019) · Schizophrenia · doi:10.1038/s41537-019-0071-2 · Cited by 65
Self-citationAbate, G., Frisoni, G. B., Bourdon, J., Piccirella, S., Memo, M., & Uberti, D. L. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00732-0 · Cited by 62
Oxidative Stress and Aberrant Cell Cycle in Alzheimer’s Disease Lymphocytes: Diagnostic Prospects
Wojsiat, J., Prandelli, C., Laskowska-Kaszub, K., Martín-Requero, A., & Wojda, U. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141977 · Cited by 54
Regulator of Cell Cycle (RGCC) Expression during the Progression of Alzheimer's Disease
Counts, S., & Mufson, E. J. (2017) · Cell Transplantation · doi:10.3727/096368916x694184 · Cited by 60
Fabbri, C., Kasper, S., Kautzky, A., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G., Ferentinos, P. P., Rujescu, D., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0738-5 · Cited by 51
Skovira, J. W., Wu, J., Matyas, J. J., Kumar, A., Hanscom, M., Kabadi, S. V., Fang, R. S., & Faden, A. I. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0769-2 · Cited by 52
Re-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die?
Sharma, R. R., Kumar, D., Jha, N. K., Jha, S. K., Ambasta, R. K., & Kumar, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.09.010 · Cited by 45
Tau and DNA Damage in Neurodegeneration
Colnaghi, L., Rondelli, D., Muzi-Falconi, M., & Sertic, S. (2020) · Brain Sciences · doi:10.3390/brainsci10120946 · Cited by 43
“The lesions are likely caused by ROS produced by Aβ and tau oligomers, and their onset is accompanied by the activation of DDR kinases, such as ATM, that can phosphorylate a plethora of targets [79,80].”
BackgroundBRCA1 and p53 Tumor Suppressor Molecules in Alzheimer’s Disease
Nakanishi, A., Minami, A., Kitagishi, Y., Ogura, Y., & Matsuda, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16022879 · Cited by 46
Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors
Fadaka, A. O., Bakare, O. O., Sibuyi, N. R. S., & Klein, A. (2020) · Cancers · doi:10.3390/cancers12030662 · Cited by 45
“In neurodegenerative diseases, CHEK1 abnormalities were associated with dementia and loss of protection in Alzheimer’s disease [10].”
BackgroundClark, J., Piccirella, S., Kayed, R., Abate, G., Uberti, D. L., & Kinnon, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.835288 · Cited by 43
“However, there are several conflicting studies showing expression of TIGAR is inversely correlated with the severity of AD, although in mild dementia, downregulation of TIGAR was noted in the superior temporal cortex (Sablina et al., 2005; Katsel et al., 2013).”
BackgroundResultRegion- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration
Shepherd, C. E., Yang, Y., & Halliday, G. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.050 · Cited by 37
DNA damage and neurodegenerative phenotypes in aged Ciz1 null mice
Khan, M. M., Xiao, J., Patel, D., & LeDoux, M. S. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.014 · Cited by 43
“…in cell-cycle and DNA repair pathways lead to uncontrolled cell death and play an important role in the pathogenesis of several age-related neurodegenerative disorders (Adamec et al., 1999, Best, 2009, Chen et al., 2010, Gensler and Bernstein, 1981, Katsel et al., 2013, Ioannidou et al., 2016).”
BackgroundInfluentialYates, S. C., Zafar, A., Rabai, E. M., Foxall, J. B., Nagy, S., Morrison, K. E., Clarke, C., Esiri, M. M., Christie, S., Smith, A. D., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0114050 · Cited by 31
“The finding is also consistent with recent findings of deficient p53-dependent DNA damage repair, which requires a fully functional p21 [59] in AD [73].”
ResultAltered expression of mRNA profiles in blood of early-onset schizophrenia
Xu, Y. J., Shugart, Y. Y., Wang, G., Cheng, Z., Jin, C., Zhang, K., Wang, J., Yu, H., Yue, W., Zhang, F., et al. (2016) · Scientific Reports · doi:10.1038/srep16767 · Cited by 30
Extracellular vesicle miRNAs in breast milk of obese mothers
Cho, Y. E., Vorn, R., Chimenti, M. S., Crouch, K., Chen, S., Narayanaswamy, J., Harken, A., Schmidt, R., Gill, J., & Lee, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.976886 · Cited by 31
Kwiatkowski, D., Czarny, P. L., Toma, M. M., Imiela, A., Sowinska, K., Gałecki, P., Bachurska, A., Bielecka-Kowalska, A., Szemraj, J., Maes, M. H. J., et al. (2016) · Neuropsychobiology · doi:10.1159/000444643 · Cited by 26
Tang, Y., Kwon, H., Neel, B. A., Meron, M. K., Pessin, J. B., Yamada, E., & Pessin, J. E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002727 · Cited by 24
Iourov, I. Y., Vorsanova, S. G., Zelenova, M. A., Korostelev, S. A., & Yurov, Y. B. (2015) · International Journal of Genomics · doi:10.1155/2015/757680 · Cited by 23
Li, X., Cao, G., Liu, X., Tang, T.-S., Guo, C., & Liu, H. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.852002 · Cited by 32
Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division
Gupta, R. V., Jha, A., Ambasta, R. K., & Kumar, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120006 · Cited by 21
The Role of Gene Editing in Neurodegenerative Diseases
Fan, H.-C., Chi, C.-S., Lee, Y.-J., Tsai, J., Lin, S., & Harn, H.-J. (2018) · Cell Transplantation · doi:10.1177/0963689717753378 · Cited by 23
Shukla, M., & Vincent, B. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230314142505 · Cited by 18
Piccirella, S., Neste, L. V., Fowler, C., Masters, C. L., Fripp, J., Doecke, J. D., Xiong, C., Uberti, D. L., & Kinnon, P. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.52 · Cited by 17
Environmental Neurotoxins Linked to a Prototypical Neurodegenerative Disease
Spencer, P. S., Garner, C. E., Palmer, V. S., & Kisby, G. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00011-x · Cited by 21
Zhang, Z., Zhang, Z., Wang, H., Zhang, G., Hu, D., Xiong, J., Xiong, N., Wang, T., Cao, X., & Mao, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106669 · Cited by 15
“Some neurons even completed nearly full DNA replication of S phase [1,4,5,23].”
BackgroundHorizontal and vertical integrative analysis methods for mental disorders omics data
Wang, S., Shi, X., Wu, M., & Ma, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-49718-5 · Cited by 15
Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases
Fan, H., Chi, C.-S., Cheng, S.-N., Lee, H.-F., Tsai, J., Lin, S., & Harn, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010026 · Cited by 12
TIGAR inclusion pathology is specific for Lewy body diseases
Robles-Lopez, K., Simpson, J. E., Watson, L. C., Mortiboys, H., Hautbergue, G. M., Bandmann, O., & Highley, J. R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.09.032 · Cited by 13
The role of TIGAR in nervous system diseases
Huang, B., Lang, X., & Li, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1023161 · Cited by 11
“Mice Katsel, 2013 AD At different stages of AD dementia severity, the role of ATM-p53 signaling in countering glycolysis/oxygen-phosphorus-induced cell death diminished (Katsel et al., 2013).”
BackgroundCan accelerated ageing models inform us on age‐related tauopathies?
Han, Z. Z., Fleet, A., & Larrieu, D. (2023) · Aging Cell · doi:10.1111/acel.13830 · Cited by 11
Melatonin Supplementation in Alzheimer’s disease: The Potential Role in Neurogenesis
Ebrahimi, R., Faramarzi, A., Salarvandian, S., Zarei, R., Heidari, M., Salehian, F., & Esmaeilpour, K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05095-x · Cited by 8
“Meanwhile, TP53-induced glycolysis and apoptosis regulator (TIGAR), which is a downstream target of the ATM-p53 signaling pathway that offers protection against oxidative stress, shows a gradual decline in its expression [243].”
Katsel, P., Fam, P. S., Tan, W., Khan, S., Yang, C., Jouroukhin, Y., Rudchenko, S., Pletnikov, M. V., & Haroutunian, V. H. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx106 · Cited by 8
Self-citationC12orf5 (chromosome 12 open reading frame 5)
Simon‐Molas, H., Rodríguez‐García, A., Navarro‐Sabaté, À., Fontova, P., Bartrons, R., & Manzano, À. (2014) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/53971 · Cited by 5
Colacurcio, D. J., Zyskind, J. W., Jordan‐Sciutto, K. L., & Akay, C. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.031 · Cited by 4
“A previous study observed a small, but significant increase in MDMx mRNA in patients with AD, but this change did not associate with changes in plaque density or Braak staging [55].”
ResultEstratégias terapêuticas baseadas nos mecanismos fisiopatológicos conhecidos na Doença de Alzheimer
Janeiro, D. I. S. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
“MIRAI” Healthcare: “Future” in Japanese
Fujii, Y. R. (2023) · Springer eBooks · doi:10.1007/978-981-99-3165-1_10
Rosmanah, L. (2024) · Indonesian Journal of Primatology · doi:10.29244/primatology.2.02.68-75 · Cited by 1
Wei, X., Yan, R., Wang, S., Jiang, Y., Li, H., & Li, Y. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340878
Metadata
- Authors
- Katsel, P., Tan, W., Fam, P., Purohit, D. P., & Haroutunian, V.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- James J. Peters VA Medical Center (US)
- Corresponding author
- Katsel, Pavel
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-05
- Volume
- 8
- Issue
- 7
- Pages
- e68361
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3702571
- OpenAlex
- W1972266320
- Cited by
- 52
- References
- 89
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 7 · 2017: 4 · 2016: 4 · 2015: 8 · 2014: 7
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-07-17)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Leir Foundation
- National Institutes of Health (MH066392, AG05138, AG02219)
- National Institute on Aging (P50 AG 05138, P01 AG 02219, P50AG005138, P01AG002219)
- National Institute of Mental Health (P50MH066392, MH066392, R01MH064673, MH-064673)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- Alzheimer's disease, dementia, cell cycle checkpoint proteins, oxidative stress, ATM signaling, p53, DNA damage response, TIGAR, MDM4, ATR, Chk1, BRCA1, superior temporal cortex, mitochondrial dysfunction, schizophrenia, gene expression, neurodegeneration
- MeSH terms
- Alzheimer Disease, Autopsy, Dementia, DNA Damage, Humans, Phosphoric Monoester Hydrolases, Temporal Lobe, Oxidative Stress, Disease Progression, Intracellular Signaling Peptides and Proteins, Apoptosis Regulatory Proteins, Gene Regulatory Networks, Cell Cycle Checkpoints, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.